|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquisition
|
gptkb:Glaxo_Wellcome
gptkb:Zy_Co_V-D
gptkb:Smith_Kline_Beecham
|
|
gptkbp:annual_report
|
publishes annual reports
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:capital
|
approximately £80 billion (2021)
|
|
gptkbp:ceo
|
gptkb:Emma_Walmsley
|
|
gptkbp:clinical_trial
|
ongoing
innovative
collaborative
conducts clinical trials globally
invests in clinical research
conducts Phase I, II, III trials
|
|
gptkbp:collaborations
|
various universities
|
|
gptkbp:community_engagement
|
engages in community health initiatives
|
|
gptkbp:competitors
|
gptkb:Johnson_&_Johnson
gptkb:Astra_Zeneca
gptkb:Pfizer
gptkb:Merck_&_Co.
gptkb:Novartis
|
|
gptkbp:conducts_research_on
|
gptkb:Dr._Hal_Barron
|
|
gptkbp:dividend_yield
|
pays dividends to shareholders
|
|
gptkbp:divisions
|
gptkb:pharmaceuticals
vaccines
consumer healthcare
|
|
gptkbp:employees
|
99,000 (2020)
|
|
gptkbp:financial_reports
|
annual reports available
|
|
gptkbp:focus
|
research and development
|
|
gptkbp:founded
|
gptkb:2000
|
|
gptkbp:has_research_center
|
has research facilities in Belgium
has research facilities in China
has research facilities in the UK
has research facilities in the US
|
|
gptkbp:head_of_global_manufacturing
|
gptkb:Dr._Roger_Connor
|
|
gptkbp:headquarters
|
gptkb:Brentford,_England
Brentford, London, England
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
GSK plc
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:invention
|
numerous
holds numerous patents
|
|
gptkbp:investment_strategy
|
monitored on stock exchanges
|
|
gptkbp:is_vulnerable_to
|
developed a COVID-19 vaccine
|
|
gptkbp:market
|
global market
|
|
gptkbp:market_cap
|
£80 billion (2021)
|
|
gptkbp:operates_in
|
global market
|
|
gptkbp:partnership
|
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:CEPI
gptkb:Pfizer
gptkb:Novartis
|
|
gptkbp:partnerships
|
gptkb:Bill_&_Melinda_Gates_Foundation
partners with academic institutions
partners with healthcare organizations
partners with governments
|
|
gptkbp:philanthropy
|
gptkb:healthcare_access
community support
education initiatives
|
|
gptkbp:products
|
antibiotics
vaccines
antidepressants
respiratory medicines
|
|
gptkbp:research_areas
|
neurology
oncology
infectious diseases
immunology
respiratory diseases
|
|
gptkbp:research_focus
|
neurology
oncology
infectious diseases
immunology
|
|
gptkbp:research_institutes
|
gptkb:GSK_Vaccines_Institute_for_Global_Health
GSK's R& D centers
|
|
gptkbp:revenue
|
£34.1 billion (2020)
|
|
gptkbp:social_responsibility
|
corporate social responsibility programs
|
|
gptkbp:stock_exchange
|
gptkb:New_York_Stock_Exchange
gptkb:London_Stock_Exchange
|
|
gptkbp:stock_symbol
|
gptkb:GSK
|
|
gptkbp:subsidiaries
|
gptkb:Vii_V_Healthcare
HIV research
|
|
gptkbp:subsidiary
|
gptkb:Vii_V_Healthcare
HIV research
|
|
gptkbp:sustainability_efforts
|
reduce carbon emissions
improve access to medicines
support global health initiatives
|
|
gptkbp:sustainability_initiatives
|
community health programs
environmental impact reduction
access to medicines
|
|
gptkbp:trademark
|
numerous
|
|
gptkbp:vaccine_collaboration
|
collaborated with Sanofi
|
|
gptkbp:website
|
www.gsk.com
|
|
gptkbp:bfsParent
|
gptkb:Mylan_Laboratories_Limited
|
|
gptkbp:bfsLayer
|
6
|